Chronic myeloid leukemia-leukemia cutis mimicking a neutrophilic panniculitis-like leukemia cutis: Report of a rare case. 2021

Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.

While drug-induced panniculitis is not uncommon in chronic myeloid leukemia (CML) patients on tyrosine kinase inhibitor therapy, it is rare for CML to initially present as a leukemic panniculitis. We present the case of a 45-year-old male with no relevant prior medical history presenting with 6 months of migratory nodules, 2 months of drenching night sweats, and a 20 pound weight loss. Physical examination showed firm subcutaneous nodules with overlying ecchymoses present on the right lateral thigh and left lower back. Biopsy of a nodule from the right thigh showed a subcutaneous lobular panniculitis involved by a dense infiltrate of neutrophils and granulocyte precursors. Fluorescent in-situ hybridization (FISH) was positive for t(9;22)(q34;q11.2)BCR-ABL1 fusion. A concurrent hemogram revealed a white blood cell count elevation of 600,000 K/μL. Bone marrow biopsy examination showed marked myeloid expansion with an increase in granulocyte precursors and Philadelphia chromosome positivity by FISH, consistent with bone marrow involvement by CML. Herein, we describe this unusual and rare case of CML initially presenting as a neutrophilic panniculitis-like leukemia cutis. Arriving at this challenging diagnosis may be easily missed without clinical and laboratory correlation, which would certainly lead to the patient's not receiving life-saving treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D015434 Panniculitis General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules. Panniculitis, Subacute Nodular Migratory,Cold Panniculitis,Cold Panniculitides,Panniculitides,Panniculitides, Cold,Panniculitis, Cold
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias

Related Publications

Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
January 2015, International journal of health sciences,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
September 2014, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
January 2019, Cancer biology & therapy,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
April 2024, Clinical case reports,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
January 2006, Annals of Saudi medicine,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
December 1987, Chinese medical journal,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
October 2001, Indian journal of pathology & microbiology,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
March 1995, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
July 2020, Leukemia research,
Brandon Zelman, and Olaoluwa Bode-Omoleye, and Aaron Muhlbauer, and Ada Agidi, and Mariam Mafee, and Milind Velankar, and Kamran Mirza, and Jodi Speiser, and Kumaran Mudaliar
February 2001, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!